Robert Thomas Freeman Sells 6,744 Shares of Alignment Healthcare, Inc. (NASDAQ:ALHC) Stock

Alignment Healthcare, Inc. (NASDAQ:ALHC) CFO Robert Thomas Freeman sold 6,744 shares of Alignment Healthcare stock in a transaction on Thursday, March 27th. The stock was sold at an average price of $17.89, for a total value of $120,650.16. Following the transaction, the chief financial officer now directly owns 1,464,419 shares of the company’s stock, valued at $26,198,455.91. This trade represents a 0.46 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Robert Thomas Freeman also recently made the following trade(s):

• On Tuesday, March 18th, Robert Thomas Freeman sold 13,815 shares of Alignment Healthcare stock. The shares were sold at an average price of $16.89, for a total transaction of $233,335.35.
• On Wednesday, March 12th, Robert Thomas Freeman sold 14,692 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.43, for a total transaction of $226,697.56.
• On Thursday, March 6th, Robert Thomas Freeman sold 218,295 shares of Alignment Healthcare stock. The stock was sold at an average price of $15.53, for a total transaction of $3,390,121.35.
• On Tuesday, March 4th, Robert Thomas Freeman sold 250,000 shares of Alignment Healthcare stock. The shares were sold at an average price of $15.58, for a total value of $3,895,000.00.

Alignment Healthcare Price Performance

Shares of Alignment Healthcare stock opened at $18.30 on Friday. The business’s fifty day moving average price is $15.28 and its 200 day moving average price is $13.00. Alignment Healthcare, Inc. has a twelve month low of $4.46 and a twelve month high of $18.44. The company has a current ratio of 1.60, a quick ratio of 1.60 and a debt-to-equity ratio of 1.82. The stock has a market capitalization of $3.51 billion, a P/E ratio of -23.77 and a beta of 1.49.

Hedge Funds Weigh In On Alignment Healthcare

Several hedge funds and other institutional investors have recently modified their holdings of ALHC. Wellington Management Group LLP boosted its holdings in Alignment Healthcare by 77.9% in the 4th quarter. Wellington Management Group LLP now owns 7,438,500 shares of the company’s stock worth $83,683,000 after acquiring an additional 3,257,630 shares during the period. Mackenzie Financial Corp boosted its stake in shares of Alignment Healthcare by 149.8% in the fourth quarter. Mackenzie Financial Corp now owns 85,175 shares of the company’s stock valued at $958,000 after purchasing an additional 51,084 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its holdings in Alignment Healthcare by 15.9% during the 4th quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 263,203 shares of the company’s stock valued at $2,961,000 after purchasing an additional 36,151 shares in the last quarter. Voloridge Investment Management LLC acquired a new position in shares of Alignment Healthcare in the fourth quarter worth about $189,000. Finally, Squarepoint Ops LLC boosted its holdings in Alignment Healthcare by 414.6% in the fourth quarter. Squarepoint Ops LLC now owns 198,309 shares of the company’s stock valued at $2,231,000 after purchasing an additional 159,774 shares during the last quarter. 86.19% of the stock is owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on ALHC shares. Barclays upped their price objective on Alignment Healthcare from $8.00 to $9.00 and gave the company an “underweight” rating in a research report on Friday, February 28th. Stephens reaffirmed an “overweight” rating and set a $17.00 price target on shares of Alignment Healthcare in a research note on Monday, February 24th. Piper Sandler boosted their price objective on shares of Alignment Healthcare from $14.00 to $21.00 and gave the company an “overweight” rating in a research report on Tuesday, March 4th. Bank of America raised their target price on shares of Alignment Healthcare from $15.50 to $18.50 and gave the stock a “buy” rating in a research report on Tuesday, March 4th. Finally, William Blair reiterated an “outperform” rating on shares of Alignment Healthcare in a report on Friday, February 28th. One research analyst has rated the stock with a sell rating, three have issued a hold rating, seven have issued a buy rating and one has given a strong buy rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $14.83.

About Alignment Healthcare

Alignment Healthcare, Inc, a tech-enabled Medicare advantage company, operates consumer-centric health care platform for seniors in the United States. It provides customized health care designed to meet the needs of a diverse array of seniors through its Medicare advantage plans. The company was founded in 2013 and is based in Orange, California.